UNSPSC 85704031: Revision of nonautologous tissue substitute in left femoral shaft, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in left femoral shaft, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QW94KZ

UNSPSC 85704031, Revision of nonautologous tissue substitute in left femoral shaft, percutaneous endoscopic approach, is a Commodity code that shows no alignment with recent state and local procurement activity. The code nominally describes a specific orthopedic surgical procedure, but the most recent opportunities posted under this code involve occupational medical surveillance, independent disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical benefit carve-outs, and emergency services for youth in custody — none of which involve the tissue-revision procedure named in the code. State and local procurement offices have tagged these six opportunities (posted between July and September 2026 across Arizona, California, Florida, and Washington) with this code despite their lack of connection to the underlying clinical service. This suggests either a data-tagging error in the source system or the code's misapplication to broader health services categories that the state and local procurement taxonomy does not address with precision.

The geographic spread spans Arizona (City of Phoenix), California (City of Long Beach, County of Santa Clara), Florida (Collier County), Washington (Washington State Department of Transportation), and Texas (Harris County), with issuing bodies ranging from municipal retirement offices and county health systems to state transportation departments. No representative opportunities directly match the code's stated scope of orthopedic surgical revision. Without recent solicitations explicitly procuring nonautologous tissue substitutes or related implantable devices under this code, the code presents minimal decision relevance for business development targeting state and local procurement in the named category.